Markets:

Overview

News

Currencies

International

Treasuries

Ventyx Biosciences, Inc. - Common Stock (NQ:VTYX)

13.84 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ventyx Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

VTYX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Ventyx Biosciences, Inc. is Fair to Shareholders

January 08, 2026

From Halper Sadeh LLC

Via Business Wire

Nasdaq, S&P 500 Futures Dip As Investors Brace For Jobs Data, Tariff Ruling: Why NVDA, MSFT, AAPL, APLD, NIO Are On Traders' Radar Today ↗

January 08, 2026

Nvidia, Apple, Microsoft, and select biotech names dominated early market buzz.

Via Stocktwits

Topics ETFs Government Stocks

Ventyx’s $1.2B Buyout By Eli Lilly Proves Timing Often Beats Conviction In Biotech Investing — A VC Explains ↗

January 07, 2026

Bottom buyers saw over 2,000% gains, while IPO investors merely broke even after a 90% drawdown, according to Atlas Venture’s Bruce Booth.

Via Stocktwits

Topics Initial Public Offering

Eli Lilly To Acquire Ventyx Biosciences In $1.2 Billion Deal ↗

January 07, 2026

Lilly will acquire all of the outstanding shares of Ventyx for $14 per share of common stock in an all-cash transaction.

Via Stocktwits

Wednesday's pre-market session: top gainers and losers ↗

January 07, 2026

Via Chartmill

Nasdaq, S&P 500 Futures Tread Water Ahead Of ADP Data: Why NVDA, META, APLD, VTYX, ALMS Are On Traders' Radar Today ↗

January 07, 2026

Via Stocktwits

Topics Stocks

Tuesday's after hours session: top gainers and losers ↗

January 06, 2026

Via Chartmill

Ventyx Biosciences Stock Jumps On Reports Of Eli Lilly Buyout ↗

January 06, 2026

A deal for Ventyx could be announced imminently, the Wall Street Journal reported, citing people familiar with the matter.

Via Stocktwits

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX

January 06, 2026

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX

December 30, 2025

From Pomerantz LLP

Via GlobeNewswire

Ventyx Provides Clinical and Corporate Updates

December 02, 2025

From Ventyx Biosciences, Inc.

Via GlobeNewswire

Ventyx Biosciences to Participate in the Piper Sandler 37th Annual Healthcare Conference

December 01, 2025

From Ventyx Biosciences, Inc.

Via GlobeNewswire

Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference in London

November 17, 2025

From Ventyx Biosciences, Inc.

Via GlobeNewswire

Which stocks have an unusual volume on Friday? ↗

October 24, 2025

Volume analysis on 2025-10-24: stocks with an unusual volume in today's session.

Via Chartmill

Crude Oil Surges 5%; American Airlines Shares Jump After Q3 Results ↗

October 23, 2025

Via Benzinga

Here are the top movers in Thursday's session. ↗

October 23, 2025

Intrigued by the market activity one hour before the close of the markets on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

Most active stocks in Thursday's session ↗

October 23, 2025

Discover the most active stocks in Thursday's session. Stay informed about the stocks that are generating the most trading volume!

Via Chartmill

Ventyx Stock Is Rallying Thursday: What's Driving The Surge? ↗

October 23, 2025

Ventyx Biosciences Inc (NASDAQ:VTYX) shares are surging Thursday after the company announced positive Phase 2 study results for VTX3232.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 23, 2025

Via Benzinga

Which stocks are moving on Thursday? ↗

October 23, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

These stocks are gapping in today's session ↗

October 23, 2025

The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.

Via Chartmill

Dow Gains 50 Points; Tesla Shares Slide After Q3 Earnings ↗

October 23, 2025

Via Benzinga

Topics Stocks

Wondering what's happening in today's pre-market session? ↗

October 23, 2025

Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 23, 2025

Via Benzinga

Why LendingClub Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗

October 23, 2025

Via Benzinga

Ventyx Biosciences Stock: Retail Buzz Spikes After Phase 2 Win In Obesity And Heart Risk Study ↗

October 23, 2025

The Phase 2 trial showed VTX3232 cut key inflammation markers like hsCRP by about 78% and IL-6 to below risk thresholds, reinforcing its anti-inflammatory potential.

Via Stocktwits

Why Ventyx (VTYX) Shares Soared 86.5% After Hours? ↗

October 23, 2025

Ventyx shares jumped 86.5% in after-hours trading after positive Phase 2 trial results.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 22, 2025

Via Benzinga

Which stocks are moving after the closing bell on Wednesday? ↗

October 22, 2025

Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

Ventyx Biosciences Announces Positive Topline Results from Phase 2 Study of VTX3232 in Participants with Obesity and Cardiovascular Risk Factors

October 22, 2025

From Ventyx Biosciences, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.